SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nature Boy who wrote (87)7/28/1999 7:44:00 AM
From: telephonics  Read Replies (1) of 226
 
Thanks for the info.I was not aware of this situation. The RatCom-2 channel DNA analysis System is for real. The research arm of the FDA whose laboratories are on the NIH campus are processing an order for a system to be devoted to studying a blood cancer problem called Chronic Lymphatic Lymphoma.(CLL) This research group utilizing several of the last generation flow cytometers over the past 12 years have been totally unsuccessful in defining this problem which affects about 8% of all Americans over 60 years of age.A blood sample from a CLL sufferer at the NIH was tested and the results were electifying.The reaction from the research group was astounding.This test had never been run on the RatCom system and was subsequently run with different samples the next two days with superb results.
There are an ever increasing number of tissue samples being obtained which is building the data base which eventually will be used in making application to the FDA.Currently the company has systems installed at Johns Hopkins,The Sylvester Comprehensive Cancer Center ( Univ of Miami),Reed- Hardeman University in Tenn,and is anticipating providing a system to the hospital associated with the Catholic University in Rome,Italy.The future prospects IMHO are very bright. One other item:The Sylvester researchers have data that indicates that needle biopsies provide sufficient number of cells for a diagnosis to be run. With only a three minute run time such an aspiration could be done in a Doctor's office and the breast cancer diagnosis world would undergo a radical change.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News